Burning Rock Biotech Ltd cotiza a 15.00 USD y tiene una capitalización bursátil de $158M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-base…
| Periodo | 2023-05 | 2023-03 | 2022-11 | 2022-08 |
|---|---|---|---|---|
| Real | $-18.10 | $-21.10 | $-23.30 | $-25.00 |
| Estimado | $-13.90 | $-19.00 | $-18.80 | $-18.50 |
| Sorpresa | -30.2% | -11.1% | -23.9% | -35.1% |
| Métrica | BNR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 74.7% | 57.0% | +17.6% |
| Operating Margin | -10.2% | -38.6% | +28.5% |
| Net Margin | -10.3% | -33.6% | +23.3% |
| FCF Margin | -6.2% | -13.9% | +7.6% |
| ROE | -10.3% | -40.4% | +30.1% |
| ROA | -6.8% | -32.0% | +25.3% |
| Current Ratio | 2.99 | 2.84 | +0.15 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |